Harpoon Therapeutics Inc. (HARP) NASDAQ

$23.01 0.02 (0.09%)

Market Cap: -

As of 03/08/24 04:00 PM EST. Market closed.

(HARP)

Harpoon Therapeutics Inc. (HARP)
NASDAQ

$23.01
0.02 (0.09%)

Market Cap: -

As of 03/08/24 04:00 PM EST. Market closed.

Add to Portfolio

harpoon therapeutics is a pre-clinical stage biotechnology company co-founded by patrick bauerle, a pioneer in t-cell engagement, and luke evnin (mpm capital) in 2015 to develop and commercialize a novel class of t cell recruiting antibodies engage a patient’s own immune cells to fight cancer and other diseases. the world-class team of protein engineers and immunologists at harpoon have built ... read more

harpoon therapeutics is a pre-clinical stage biotechnology company co-founded by patrick bauerle, a pioneer in t-cell engagement, and luke evnin (mpm capital) in 2015 to develop and commercialize a novel class of t cell recruiting antibodies engage a patient’s own immune cells to fight cancer and other diseases. the world-class team of protein engineers and immunologists at harpoon have built upon the successful development of the bispecific (“bite™ or bispecific t cell engager”) antibody blincyto® to create a next-generation company dedicated to the development of novel non-antibody biologic therapies with improved efficacy and broad applicability in the treatment of human cancers and other life-altering diseases of the immune system. harpoon’s tri-specific t-cell redirection platform -- tritac™ -- was designed to address the needs of cancer patients not being met by current checkpoint inhibitors, bi-specifics, car-t and other t-cell engaging approaches by improving ? activity against read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
131 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1910.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Gerald McMahon
Address
131 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1910.
PRICE CHART FOR HARPOON THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$22.99
Days Range
$22.99 - $23.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
16,932,272
Open
-
Previous Close
$22.99
Days Range
$22.99 - $23.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
16,932,272
FINANCIAL STATEMENTS FOR HARPOON THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR HARPOON THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Merck & Co., Inc.10% OwnerMar 11, 2024 Buy$23.0021,397,205492,135,7151,000Mar 11, 2024, 03:27 PM
HUNT RONALDDirectorMar 23, 2023 Buy$1000.0010,00010,000,00010,000Mar 27, 2023, 05:37 PM
Erbez GeorgiaChief Financial OfficerSep 22, 2021 Buy$8.1010,30083,43019,215Sep 22, 2021, 09:30 PM
New Leaf Ventures III, L.P.10% OwnerJan 11, 2021 Buy$17.00235,2943,999,998913,860Aug 12, 2021, 04:15 PM
HUNT RONALDDirectorJan 11, 2021 Buy$17.00235,2943,999,998913,860Aug 12, 2021, 04:15 PM
Wesche HolgerChief Scientific OfficerJul 01, 2021 Option Exercise$0.6010,0006,00062,852Jul 06, 2021, 06:01 PM
Wesche HolgerChief Scientific OfficerJul 01, 2021 Sale$14.0010,000140,00052,852Jul 06, 2021, 06:01 PM
GADICKE ANSBERT10% OwnerJun 02, 2021 Sale$20.5025,118514,9196,328,095Jun 02, 2021, 06:09 PM
GADICKE ANSBERT10% OwnerJun 01, 2021 Sale$20.4418,491377,9566,353,213Jun 02, 2021, 06:09 PM
GADICKE ANSBERT10% OwnerMay 28, 2021 Sale$21.1213,885293,3156,374,904Jun 02, 2021, 06:09 PM
GADICKE ANSBERT10% OwnerMay 27, 2021 Sale$20.2613,961282,8506,385,589May 27, 2021, 07:40 PM
GADICKE ANSBERT10% OwnerMay 26, 2021 Sale$20.043,19864,0886,399,550May 27, 2021, 07:40 PM
GADICKE ANSBERT10% OwnerMay 24, 2021 Sale$20.125,000100,6006,402,748May 24, 2021, 08:11 PM
GADICKE ANSBERT10% OwnerMay 21, 2021 Sale$20.2110,907220,4306,407,748May 24, 2021, 08:11 PM
GADICKE ANSBERT10% OwnerMay 20, 2021 Sale$20.3411,713238,2426,418,655May 20, 2021, 07:20 PM
GADICKE ANSBERT10% OwnerMay 19, 2021 Sale$20.3917,833363,6156,430,368May 20, 2021, 07:20 PM
GADICKE ANSBERT10% OwnerMay 18, 2021 Sale$20.6718,402380,3696,448,201May 20, 2021, 07:20 PM
GADICKE ANSBERT10% OwnerMay 17, 2021 Sale$20.074,66693,6476,466,603May 17, 2021, 05:23 PM
GADICKE ANSBERT10% OwnerMay 14, 2021 Sale$20.046,900138,2766,471,269May 17, 2021, 05:23 PM
GADICKE ANSBERT10% OwnerMay 13, 2021 Sale$20.064,85597,3916,478,169May 17, 2021, 05:23 PM
GADICKE ANSBERT10% OwnerMay 05, 2021 Sale$22.5210,172229,1076,551,345May 06, 2021, 04:05 PM
GADICKE ANSBERT10% OwnerApr 21, 2021 Sale$18.978,972170,2297,020,675Apr 22, 2021, 04:04 PM
GADICKE ANSBERT10% OwnerApr 16, 2021 Sale$19.865,847116,1107,061,697Apr 20, 2021, 06:07 PM
GADICKE ANSBERT10% OwnerApr 20, 2021 Sale$18.7122,249416,3827,029,926Apr 20, 2021, 06:07 PM
GADICKE ANSBERT10% OwnerApr 19, 2021 Sale$19.3010,056194,0597,051,441Apr 20, 2021, 06:07 PM
MPM BioVentures 2014, L.P.Former 10% OwnerApr 13, 2021 Sale$19.461,94337,8063,223,853Apr 15, 2021, 08:01 PM
MPM BioVentures 2014, L.P.Former 10% OwnerApr 15, 2021 Sale$20.491,05221,5553,220,844Apr 15, 2021, 08:01 PM
MPM BioVentures 2014, L.P.Former 10% OwnerApr 14, 2021 Sale$20.771,67134,7143,223,446Apr 15, 2021, 08:01 PM
GADICKE ANSBERT10% OwnerApr 15, 2021 Sale$20.498,696178,1817,067,244Apr 15, 2021, 08:00 PM
GADICKE ANSBERT10% OwnerApr 14, 2021 Sale$20.7713,806286,8097,088,746Apr 15, 2021, 08:00 PM
GADICKE ANSBERT10% OwnerApr 13, 2021 Sale$19.4616,054312,3697,092,108Apr 15, 2021, 08:00 PM
MPM BioVentures 2014, L.P.10% OwnerApr 12, 2021 Sale$21.022,49652,4603,226,369Apr 13, 2021, 04:12 PM
MPM BioVentures 2014, L.P.10% OwnerApr 09, 2021 Sale$23.6710,300243,8013,228,006Apr 13, 2021, 04:12 PM
Wesche HolgerChief Scientific OfficerApr 01, 2021 Option Exercise$0.6010,0006,00062,852Apr 05, 2021, 05:00 PM
Wesche HolgerChief Scientific OfficerApr 01, 2021 Sale$20.4510,000204,49153,352Apr 05, 2021, 05:00 PM
Erbez GeorgiaChief Financial OfficerFeb 17, 2021 Option Exercise$2.1225,00053,00072,292Feb 18, 2021, 08:31 AM
MPM BioVentures 2014, L.P.10% OwnerFeb 10, 2021 Sale$20.00183,0513,661,0203,238,306Feb 12, 2021, 05:03 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 10, 2021 Sale$20.00183,0513,661,0203,238,306Feb 12, 2021, 05:03 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 09, 2021 Sale$20.259,400190,3503,421,357Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 08, 2021 Sale$20.0472,1281,445,4453,430,757Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 05, 2021 Sale$20.0110,172203,5423,502,885Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 02, 2021 Sale$20.1348,421974,7153,584,709Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 04, 2021 Sale$20.3729,730605,6003,513,057Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 03, 2021 Sale$20.2141,922847,2443,542,787Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P.10% OwnerJan 27, 2021 Sale$20.00706,82514,136,5003,633,130Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P.10% OwnerJan 26, 2021 Sale$21.081,36328,7324,339,955Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P.10% OwnerJan 25, 2021 Sale$21.2313,006276,1174,341,318Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P.10% OwnerJan 22, 2021 Sale$21.7224,695536,3754,354,324Jan 22, 2021, 08:16 PM
MPM BioVentures 2014, L.P.10% OwnerJan 21, 2021 Sale$22.2226,066579,0954,384,106Jan 22, 2021, 08:16 PM
MPM BioVentures 2014, L.P.10% OwnerJan 20, 2021 Sale$24.0417,694425,2914,508,731Jan 22, 2021, 08:16 PM
Wesche HolgerChief Scientific OfficerJan 04, 2021 Option Exercise$0.6010,0006,00062,852Jan 06, 2021, 06:25 PM
Wesche HolgerChief Scientific OfficerJan 04, 2021 Sale$18.3810,000183,83759,752Jan 06, 2021, 06:25 PM
Wesche HolgerChief Scientific OfficerOct 01, 2020 Option Exercise$0.6010,0006,00062,669Oct 05, 2020, 04:25 PM
Wesche HolgerChief Scientific OfficerOct 01, 2020 Sale$16.2710,000162,73753,669Oct 05, 2020, 04:25 PM
Erbez GeorgiaChief Financial OfficerAug 19, 2020 Buy$11.405,00057,0008,915Aug 20, 2020, 06:36 PM
Erbez GeorgiaChief Financial OfficerAug 18, 2020 Buy$11.602,09824,3373,915Aug 20, 2020, 06:36 PM
Erbez GeorgiaChief Financial OfficerJul 31, 2020 Buy$10.921,81719,8421,817Aug 04, 2020, 08:32 AM
Wesche HolgerChief Scientific OfficerJul 01, 2020 Option Exercise$0.6010,0006,00062,669Jul 02, 2020, 07:18 PM
Wesche HolgerChief Scientific OfficerJul 01, 2020 Sale$16.2010,000161,98952,669Jul 02, 2020, 07:18 PM
Arix Bioscience plc10% OwnerMay 28, 2020 Sale$21.33366,5917,820,9262,193,704May 29, 2020, 04:32 PM
Arix Bioscience plc10% OwnerMay 27, 2020 Sale$22.3912,064270,1442,560,295May 29, 2020, 04:32 PM
Sacks NatalieChief Medical OfficerMay 18, 2020 Option Exercise$2.121,5223,22747,276May 20, 2020, 06:34 PM
Sacks NatalieChief Medical OfficerMay 18, 2020 Sale$14.771,52222,47945,754May 20, 2020, 06:34 PM
Wesche HolgerChief Scientific OfficerMay 12, 2020 Option Exercise$0.601,40084054,069May 13, 2020, 08:45 PM
Wesche HolgerChief Scientific OfficerMay 12, 2020 Sale$14.091,40019,72052,669May 13, 2020, 08:45 PM
Wesche HolgerChief Scientific OfficerMay 07, 2020 Option Exercise$0.605,3503,21058,019May 11, 2020, 09:37 PM
Wesche HolgerChief Scientific OfficerMay 11, 2020 Option Exercise$0.601,00060053,669May 11, 2020, 09:37 PM
Wesche HolgerChief Scientific OfficerMay 08, 2020 Option Exercise$0.601,00060053,669May 11, 2020, 09:37 PM
Wesche HolgerChief Scientific OfficerMay 07, 2020 Sale$14.135,35075,57652,669May 11, 2020, 09:37 PM
Wesche HolgerChief Scientific OfficerMay 11, 2020 Sale$14.071,00014,06552,669May 11, 2020, 09:37 PM
Wesche HolgerChief Scientific OfficerMay 08, 2020 Sale$14.001,00014,00052,669May 11, 2020, 09:37 PM
Sacks NatalieChief Medical OfficerMay 01, 2020 Option Exercise$2.125,82612,35151,580May 05, 2020, 04:35 PM
Sacks NatalieChief Medical OfficerMay 01, 2020 Sale$12.075,82670,30145,754May 05, 2020, 04:35 PM
Wesche HolgerChief Scientific OfficerApr 28, 2020 Option Exercise$0.601,25075053,919Apr 30, 2020, 04:58 PM
Wesche HolgerChief Scientific OfficerApr 28, 2020 Sale$14.051,25017,56552,669Apr 30, 2020, 04:58 PM
Sacks NatalieChief Medical OfficerApr 17, 2020 Option Exercise$2.121,0212,16546,775Apr 17, 2020, 07:10 PM
Sacks NatalieChief Medical OfficerApr 16, 2020 Option Exercise$2.125001,06046,254Apr 17, 2020, 07:10 PM
Sacks NatalieChief Medical OfficerApr 17, 2020 Sale$12.081,02112,33045,754Apr 17, 2020, 07:10 PM
Sacks NatalieChief Medical OfficerApr 16, 2020 Sale$12.005006,00045,754Apr 17, 2020, 07:10 PM
Sacks NatalieChief Medical OfficerApr 13, 2020 Option Exercise$2.124,5569,65950,310Apr 15, 2020, 04:48 PM
Sacks NatalieChief Medical OfficerApr 13, 2020 Sale$12.064,55654,95945,754Apr 15, 2020, 04:48 PM
Sacks NatalieChief Medical OfficerApr 07, 2020 Option Exercise$2.125701,20846,324Apr 08, 2020, 06:10 PM
Sacks NatalieChief Medical OfficerApr 06, 2020 Option Exercise$2.127001,48446,454Apr 08, 2020, 06:10 PM
Sacks NatalieChief Medical OfficerApr 06, 2020 Sale$12.007008,40145,754Apr 08, 2020, 06:10 PM
Sacks NatalieChief Medical OfficerApr 07, 2020 Sale$12.005706,84045,754Apr 08, 2020, 06:10 PM
Sacks NatalieChief Medical OfficerMar 17, 2020 Option Exercise$2.121,5203,22247,274Mar 18, 2020, 05:28 PM
Sacks NatalieChief Medical OfficerMar 16, 2020 Option Exercise$2.121245,755Mar 18, 2020, 05:28 PM
Sacks NatalieChief Medical OfficerMar 17, 2020 Sale$12.001,52018,24045,754Mar 18, 2020, 05:28 PM
Sacks NatalieChief Medical OfficerMar 16, 2020 Sale$12.0011245,754Mar 18, 2020, 05:28 PM
Sacks NatalieChief Medical OfficerMar 02, 2020 Option Exercise$2.125,82612,35151,580Mar 03, 2020, 09:31 PM
Sacks NatalieChief Medical OfficerMar 02, 2020 Sale$14.685,82685,52645,754Mar 03, 2020, 09:31 PM
Sacks NatalieChief Medical OfficerFeb 18, 2020 Option Exercise$2.121,5213,22547,275Feb 20, 2020, 05:11 PM
Sacks NatalieChief Medical OfficerFeb 18, 2020 Sale$15.001,52122,81545,754Feb 20, 2020, 05:11 PM
Sacks NatalieChief Medical OfficerFeb 03, 2020 Option Exercise$2.125,82612,35151,580Feb 04, 2020, 08:11 PM
Sacks NatalieChief Medical OfficerFeb 03, 2020 Sale$13.905,82681,00645,754Feb 04, 2020, 08:11 PM
Erbez GeorgiaChief Financial OfficerJan 21, 2020 Buy$14.096,70094,4186,700Jan 23, 2020, 08:34 AM
Sacks NatalieChief Medical OfficerJan 16, 2020 Option Exercise$2.121,5213,22547,275Jan 21, 2020, 08:05 PM
Sacks NatalieChief Medical OfficerJan 16, 2020 Sale$14.941,52122,72545,754Jan 21, 2020, 08:05 PM
Wesche HolgerChief Scientific OfficerJan 02, 2020 Option Exercise$0.6010,0006,00062,669Jan 06, 2020, 09:55 PM
Wesche HolgerChief Scientific OfficerJan 02, 2020 Sale$14.4010,000143,98752,669Jan 06, 2020, 09:55 PM
Sacks NatalieChief Medical OfficerJan 02, 2020 Option Exercise$2.125,82612,35151,580Jan 06, 2020, 09:46 PM
Sacks NatalieChief Medical OfficerJan 02, 2020 Sale$14.185,82682,60045,754Jan 06, 2020, 09:46 PM
Baeuerle PatrickDirectorDec 27, 2019 Sale$15.9887,3791,396,281273,953Dec 30, 2019, 05:32 PM
Sacks NatalieChief Medical OfficerDec 16, 2019 Option Exercise$2.121,5213,22547,275Dec 18, 2019, 04:14 PM
Sacks NatalieChief Medical OfficerDec 16, 2019 Sale$17.021,52125,88845,754Dec 18, 2019, 04:14 PM
Chin MarkDirectorDec 17, 2019 Sale$16.8312,476209,9692,572,359Dec 17, 2019, 09:23 PM
Chin MarkDirectorDec 16, 2019 Sale$17.0213,080222,6802,584,835Dec 17, 2019, 09:23 PM
Chin MarkDirectorDec 13, 2019 Sale$17.2111,002189,3412,597,915Dec 17, 2019, 09:23 PM
Arix Bioscience plc10% OwnerDec 17, 2019 Sale$16.8312,476209,9692,572,359Dec 17, 2019, 07:20 PM
Arix Bioscience plc10% OwnerDec 16, 2019 Sale$17.0213,080222,6802,584,835Dec 17, 2019, 07:20 PM
Arix Bioscience plc10% OwnerDec 13, 2019 Sale$17.2111,002189,3412,597,915Dec 17, 2019, 07:20 PM
Chin MarkDirectorDec 10, 2019 Sale$16.91131,6962,227,0192,608,917Dec 10, 2019, 08:07 PM
Chin MarkDirectorDec 09, 2019 Sale$18.16103,7541,884,4452,817,929Dec 10, 2019, 08:07 PM
Chin MarkDirectorDec 06, 2019 Sale$19.1547,752914,2222,844,367Dec 10, 2019, 08:07 PM
Arix Bioscience plc10% OwnerDec 10, 2019 Sale$16.91131,6962,227,0192,608,917Dec 10, 2019, 07:27 PM
Arix Bioscience plc10% OwnerDec 09, 2019 Sale$18.16103,7541,884,4452,817,929Dec 10, 2019, 07:27 PM
Arix Bioscience plc10% OwnerDec 06, 2019 Sale$19.1547,752914,2222,844,367Dec 10, 2019, 07:27 PM
Erbez GeorgiaChief Financial OfficerDec 04, 2019 Option Exercise$2.1247,292100,25947,292Dec 06, 2019, 04:41 PM
Sacks NatalieChief Medical OfficerDec 02, 2019 Option Exercise$2.125,82612,35151,580Dec 04, 2019, 04:42 PM
Sacks NatalieChief Medical OfficerDec 02, 2019 Sale$17.985,826104,75145,754Dec 04, 2019, 04:42 PM
Sacks NatalieChief Medical OfficerNov 18, 2019 Option Exercise$2.1218,25238,69464,006Nov 19, 2019, 04:24 PM
Sacks NatalieChief Medical OfficerNov 18, 2019 Sale$13.3718,252243,96446,754Nov 19, 2019, 04:24 PM
Sacks NatalieChief Medical OfficerNov 01, 2019 Option Exercise$2.125,82612,35151,580Nov 05, 2019, 04:09 PM
Sacks NatalieChief Medical OfficerNov 01, 2019 Sale$13.175,82676,70245,754Nov 05, 2019, 04:09 PM
Sacks NatalieChief Medical OfficerOct 14, 2019 Option Exercise$2.1212,45226,39858,206Oct 16, 2019, 05:14 PM
Sacks NatalieChief Medical OfficerOct 15, 2019 Option Exercise$2.1211,69824,80057,452Oct 16, 2019, 05:14 PM
Sacks NatalieChief Medical OfficerOct 15, 2019 Sale$13.2111,698154,48145,754Oct 16, 2019, 05:14 PM
Sacks NatalieChief Medical OfficerOct 14, 2019 Sale$13.2712,452165,28045,754Oct 16, 2019, 05:14 PM
McMahon Gerald PhDPresident and CEOJun 05, 2019 Option Exercise$0.60169,462101,677172,462Sep 06, 2019, 07:17 PM
McMahon Gerald PhDPresident and CEOMay 14, 2019 Buy$10.161,00010,1573,000May 16, 2019, 08:32 AM
McMahon Gerald PhDPresident and CEOMay 08, 2019 Buy$10.561,00010,5592,000May 10, 2019, 08:31 AM
McMahon Gerald PhDPresident and CEOMay 03, 2019 Buy$10.531,00010,5301,000May 07, 2019, 04:12 PM
Arix Bioscience plc10% OwnerFeb 12, 2019 Buy$14.00428,5715,999,9942,892,119Feb 14, 2019, 06:01 PM
UBS Oncology Impact Fund L.P.10% OwnerFeb 12, 2019 Buy$14.00250,0003,500,0003,898,422Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P.10% OwnerFeb 12, 2019 Sale$14.004476,2583,648,422Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P.10% OwnerFeb 12, 2019 Option Exercise$0.05127,0966,2533,648,869Feb 14, 2019, 05:34 PM
New Leaf Ventures III, L.P.10% OwnerFeb 12, 2019 Buy$14.00428,5715,999,9942,242,839Feb 14, 2019, 05:33 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 12, 2019 Buy$14.00250,0003,500,0004,524,425Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 12, 2019 Sale$14.001,52421,3364,274,425Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P.10% OwnerFeb 12, 2019 Option Exercise$0.05432,11921,2604,275,949Feb 14, 2019, 05:32 PM
HUNT RONALDDirectorFeb 12, 2019 Buy$14.00428,5715,999,9942,242,839Feb 14, 2019, 05:30 PM
GADICKE ANSBERT10% OwnerFeb 12, 2019 Buy$14.00500,0007,000,0008,422,847Feb 14, 2019, 05:28 PM
GADICKE ANSBERT10% OwnerFeb 12, 2019 Sale$14.001,97127,5947,922,847Feb 14, 2019, 05:28 PM
GADICKE ANSBERT10% OwnerFeb 12, 2019 Option Exercise$0.05559,21527,5137,924,818Feb 14, 2019, 05:28 PM
Chin MarkDirectorFeb 12, 2019 Buy$14.00428,5715,999,9942,892,119Feb 14, 2019, 05:24 PM
EVNIN LUKEDirectorFeb 12, 2019 Option Exercise$14.001,52421,3364,274,425Feb 14, 2019, 05:19 PM
EVNIN LUKEDirectorFeb 12, 2019 Buy$14.00250,0003,500,0004,524,425Feb 14, 2019, 05:19 PM
EVNIN LUKEDirectorFeb 12, 2019 Option Exercise$0.05432,11921,2604,275,949Feb 14, 2019, 05:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Merck & Co., Inc.10% Owner03/11/2024492,135,715
HUNT RONALDDirector03/23/202310,000,000
Erbez GeorgiaChief Financial Officer09/22/202183,430
New Leaf Ventures III, L.P.10% Owner01/11/20213,999,998
HUNT RONALDDirector01/11/20213,999,998
Wesche HolgerChief Scientific Officer07/01/20216,000
Wesche HolgerChief Scientific Officer07/01/2021140,000
GADICKE ANSBERT10% Owner06/02/2021514,919
GADICKE ANSBERT10% Owner06/01/2021377,956
GADICKE ANSBERT10% Owner05/28/2021293,315
GADICKE ANSBERT10% Owner05/27/2021282,850
GADICKE ANSBERT10% Owner05/26/202164,088
GADICKE ANSBERT10% Owner05/24/2021100,600
GADICKE ANSBERT10% Owner05/21/2021220,430
GADICKE ANSBERT10% Owner05/20/2021238,242
GADICKE ANSBERT10% Owner05/19/2021363,615
GADICKE ANSBERT10% Owner05/18/2021380,369
GADICKE ANSBERT10% Owner05/17/202193,647
GADICKE ANSBERT10% Owner05/14/2021138,276
GADICKE ANSBERT10% Owner05/13/202197,391
GADICKE ANSBERT10% Owner05/05/2021229,107
GADICKE ANSBERT10% Owner04/21/2021170,229
GADICKE ANSBERT10% Owner04/16/2021116,110
GADICKE ANSBERT10% Owner04/20/2021416,382
GADICKE ANSBERT10% Owner04/19/2021194,059
MPM BioVentures 2014, L.P.Former 10% Owner04/13/202137,806
MPM BioVentures 2014, L.P.Former 10% Owner04/15/202121,555
MPM BioVentures 2014, L.P.Former 10% Owner04/14/202134,714
GADICKE ANSBERT10% Owner04/15/2021178,181
GADICKE ANSBERT10% Owner04/14/2021286,809
GADICKE ANSBERT10% Owner04/13/2021312,369
MPM BioVentures 2014, L.P.10% Owner04/12/202152,460
MPM BioVentures 2014, L.P.10% Owner04/09/2021243,801
Wesche HolgerChief Scientific Officer04/01/20216,000
Wesche HolgerChief Scientific Officer04/01/2021204,491
Erbez GeorgiaChief Financial Officer02/17/202153,000
MPM BioVentures 2014, L.P.10% Owner02/10/20213,661,020
MPM BioVentures 2014, L.P.10% Owner02/10/20213,661,020
MPM BioVentures 2014, L.P.10% Owner02/09/2021190,350
MPM BioVentures 2014, L.P.10% Owner02/08/20211,445,445
MPM BioVentures 2014, L.P.10% Owner02/05/2021203,542
MPM BioVentures 2014, L.P.10% Owner02/02/2021974,715
MPM BioVentures 2014, L.P.10% Owner02/04/2021605,600
MPM BioVentures 2014, L.P.10% Owner02/03/2021847,244
MPM BioVentures 2014, L.P.10% Owner01/27/202114,136,500
MPM BioVentures 2014, L.P.10% Owner01/26/202128,732
MPM BioVentures 2014, L.P.10% Owner01/25/2021276,117
MPM BioVentures 2014, L.P.10% Owner01/22/2021536,375
MPM BioVentures 2014, L.P.10% Owner01/21/2021579,095
MPM BioVentures 2014, L.P.10% Owner01/20/2021425,291
Wesche HolgerChief Scientific Officer01/04/20216,000
Wesche HolgerChief Scientific Officer01/04/2021183,837
Wesche HolgerChief Scientific Officer10/01/20206,000
Wesche HolgerChief Scientific Officer10/01/2020162,737
Erbez GeorgiaChief Financial Officer08/19/202057,000
Erbez GeorgiaChief Financial Officer08/18/202024,337
Erbez GeorgiaChief Financial Officer07/31/202019,842
Wesche HolgerChief Scientific Officer07/01/20206,000
Wesche HolgerChief Scientific Officer07/01/2020161,989
Arix Bioscience plc10% Owner05/28/20207,820,926
Arix Bioscience plc10% Owner05/27/2020270,144
Sacks NatalieChief Medical Officer05/18/20203,227
Sacks NatalieChief Medical Officer05/18/202022,479
Wesche HolgerChief Scientific Officer05/12/2020840
Wesche HolgerChief Scientific Officer05/12/202019,720
Wesche HolgerChief Scientific Officer05/07/20203,210
Wesche HolgerChief Scientific Officer05/11/2020600
Wesche HolgerChief Scientific Officer05/08/2020600
Wesche HolgerChief Scientific Officer05/07/202075,576
Wesche HolgerChief Scientific Officer05/11/202014,065
Wesche HolgerChief Scientific Officer05/08/202014,000
Sacks NatalieChief Medical Officer05/01/202012,351
Sacks NatalieChief Medical Officer05/01/202070,301
Wesche HolgerChief Scientific Officer04/28/2020750
Wesche HolgerChief Scientific Officer04/28/202017,565
Sacks NatalieChief Medical Officer04/17/20202,165
Sacks NatalieChief Medical Officer04/16/20201,060
Sacks NatalieChief Medical Officer04/17/202012,330
Sacks NatalieChief Medical Officer04/16/20206,000
Sacks NatalieChief Medical Officer04/13/20209,659
Sacks NatalieChief Medical Officer04/13/202054,959
Sacks NatalieChief Medical Officer04/07/20201,208
Sacks NatalieChief Medical Officer04/06/20201,484
Sacks NatalieChief Medical Officer04/06/20208,401
Sacks NatalieChief Medical Officer04/07/20206,840
Sacks NatalieChief Medical Officer03/17/20203,222
Sacks NatalieChief Medical Officer03/16/20202
Sacks NatalieChief Medical Officer03/17/202018,240
Sacks NatalieChief Medical Officer03/16/202012
Sacks NatalieChief Medical Officer03/02/202012,351
Sacks NatalieChief Medical Officer03/02/202085,526
Sacks NatalieChief Medical Officer02/18/20203,225
Sacks NatalieChief Medical Officer02/18/202022,815
Sacks NatalieChief Medical Officer02/03/202012,351
Sacks NatalieChief Medical Officer02/03/202081,006
Erbez GeorgiaChief Financial Officer01/21/202094,418
Sacks NatalieChief Medical Officer01/16/20203,225
Sacks NatalieChief Medical Officer01/16/202022,725
Wesche HolgerChief Scientific Officer01/02/20206,000
Wesche HolgerChief Scientific Officer01/02/2020143,987
Sacks NatalieChief Medical Officer01/02/202012,351
Sacks NatalieChief Medical Officer01/02/202082,600
Baeuerle PatrickDirector12/27/20191,396,281
Sacks NatalieChief Medical Officer12/16/20193,225
Sacks NatalieChief Medical Officer12/16/201925,888
Chin MarkDirector12/17/2019209,969
Chin MarkDirector12/16/2019222,680
Chin MarkDirector12/13/2019189,341
Arix Bioscience plc10% Owner12/17/2019209,969
Arix Bioscience plc10% Owner12/16/2019222,680
Arix Bioscience plc10% Owner12/13/2019189,341
Chin MarkDirector12/10/20192,227,019
Chin MarkDirector12/09/20191,884,445
Chin MarkDirector12/06/2019914,222
Arix Bioscience plc10% Owner12/10/20192,227,019
Arix Bioscience plc10% Owner12/09/20191,884,445
Arix Bioscience plc10% Owner12/06/2019914,222
Erbez GeorgiaChief Financial Officer12/04/2019100,259
Sacks NatalieChief Medical Officer12/02/201912,351
Sacks NatalieChief Medical Officer12/02/2019104,751
Sacks NatalieChief Medical Officer11/18/201938,694
Sacks NatalieChief Medical Officer11/18/2019243,964
Sacks NatalieChief Medical Officer11/01/201912,351
Sacks NatalieChief Medical Officer11/01/201976,702
Sacks NatalieChief Medical Officer10/14/201926,398
Sacks NatalieChief Medical Officer10/15/201924,800
Sacks NatalieChief Medical Officer10/15/2019154,481
Sacks NatalieChief Medical Officer10/14/2019165,280
McMahon Gerald PhDPresident and CEO06/05/2019101,677
McMahon Gerald PhDPresident and CEO05/14/201910,157
McMahon Gerald PhDPresident and CEO05/08/201910,559
McMahon Gerald PhDPresident and CEO05/03/201910,530
Arix Bioscience plc10% Owner02/12/20195,999,994
UBS Oncology Impact Fund L.P.10% Owner02/12/20193,500,000
UBS Oncology Impact Fund L.P.10% Owner02/12/20196,258
UBS Oncology Impact Fund L.P.10% Owner02/12/20196,253
New Leaf Ventures III, L.P.10% Owner02/12/20195,999,994
MPM BioVentures 2014, L.P.10% Owner02/12/20193,500,000
MPM BioVentures 2014, L.P.10% Owner02/12/201921,336
MPM BioVentures 2014, L.P.10% Owner02/12/201921,260
HUNT RONALDDirector02/12/20195,999,994
GADICKE ANSBERT10% Owner02/12/20197,000,000
GADICKE ANSBERT10% Owner02/12/201927,594
GADICKE ANSBERT10% Owner02/12/201927,513
Chin MarkDirector02/12/20195,999,994
EVNIN LUKEDirector02/12/201921,336
EVNIN LUKEDirector02/12/20193,500,000
EVNIN LUKEDirector02/12/201921,260
Load More Insider Transactions
FUNDS WITH A POSITION IN HARPOON THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.1,500,0000.27%NewOther
BLACKSTONE INC.815,0000.04%NewOther
ADAGE CAPITAL PARTNERS GP, L.L.C.300,0000.00706%NewOther
BLACKROCK INC.249,8340.00007%576.34%Other
GEODE CAPITAL MANAGEMENT, LLC149,2620.00018%499.13%Other
ORBIMED ADVISORS LLC62,1210.00532%ExitedOther
RENAISSANCE TECHNOLOGIES LLC12,7560.00022%-48.68%Other
CHANGE IN SHARES OUTSTANDING FOR HARPOON THERAPEUTICS INC
STOCK BUYBACKS FOR HARPOON THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
3.97%
1Q
09/30/2023
03/31/2023
6.79%
2Q
09/30/2023
12/31/2022
17.19%
3Q
09/30/2023
09/30/2022
19.41%
4Q
09/30/2023
06/30/2022
19.50%
5Q
09/30/2023
03/31/2022
20.08%
6Q
09/30/2023
12/31/2021
21.22%
7Q
09/30/2023
09/30/2021
20.96%
8Q
09/30/2023
06/30/2021
21.46%
9Q
09/30/2023
03/31/2021
25.02%
10Q
09/30/2023
12/31/2020
55.06%
11Q
09/30/2023
09/30/2020
57.41%
12Q
09/30/2023
06/30/2020
58.17%
13Q
09/30/2023
03/31/2020
59.03%
14Q
09/30/2023
12/31/2019
68.88%
15Q
09/30/2023
09/30/2019
61.42%
16Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
3.97%
1Q
03/31/2023
6.79%
2Q
12/31/2022
17.19%
3Q
09/30/2022
19.41%
4Q
06/30/2022
19.50%
5Q
03/31/2022
20.08%
6Q
12/31/2021
21.22%
7Q
09/30/2021
20.96%
8Q
06/30/2021
21.46%
9Q
03/31/2021
25.02%
10Q
12/31/2020
55.06%
11Q
09/30/2020
57.41%
12Q
06/30/2020
58.17%
13Q
03/31/2020
59.03%
14Q
12/31/2019
68.88%
15Q
09/30/2019
61.42%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR HARPOON THERAPEUTICS INC
LOADING...